These innovations represent examples of the animal-free alternatives advocated by the 21st Century toxicology paradigm (i.e. NRC, USA) whereby human-derived cell/tissue data will lead to more-accurate and more-reliable public health risk assessments and therapeutic mitigations (e.g. exposure to ambient air pollutants) for lung disease.